Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
With
Eisai Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically or cytologically documented metastatic NSCLC AC (as defined by the 8th International Association for the Study of Lung Cancer Classification).
Measurable target disease assessed by the investigator according to RECIST 1.1.
Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1
You may not be if
NSCLC histologies other than AC (ie, squamous cell carcinoma, large cell carcinoma).
Significant third-space fluid retention (eg, ascites or pleural effusion) that requires repeated drainage.
Prior pneumonectomy. Prior lobectomy and segmentectomy are allowed \> 12 months before treatment.
Recent chest radiotherapy. Participants with chest or chest wall radiation may be permitted if chest radiation is documented \> 6 months before starting study treatment.
